INNOVA CAPTAB
Back to Balance Sheet
|
INNOVA CAPTAB Last 5 Year Deferred Tax Assets / Liabilities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Deferred Tax Assets / Liabilities | ₹0.95 Cr | ₹-15 Cr | ₹3.80 Cr | ₹1.84 Cr | ₹1.93 Cr |
What is the latest Deferred Tax Assets / Liabilities ratio of INNOVA CAPTAB ?
| Year | Deferred Tax Assets / Liabilities |
|---|---|
| Mar2025 | ₹0.95 Cr |
| Mar2024 | ₹-15 Cr |
| Mar2023 | ₹3.80 Cr |
| Mar2022 | ₹1.84 Cr |
| Mar2021 | ₹1.93 Cr |
How is Deferred Tax Assets / Liabilities of INNOVA CAPTAB Trending?
| Years | Deferred Tax Assets / Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | ₹0.95 Cr | Positive | |
| Mar2024 | ₹-15 Cr | Negative | |
| Mar2023 | ₹3.80 Cr | 106.91 | |
| Mar2022 | ₹1.84 Cr | -4.62 | |
| Mar2021 | ₹1.93 Cr | - | |
Compare Deferred Tax Assets / Liabilities of peers of INNOVA CAPTAB
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| INNOVA CAPTAB | ₹3,881.0 Cr | 1.5% | -5.4% | -7.8% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹431,628.0 Cr | 3.5% | 5.6% | 11.9% | Stock Analytics | |
| DIVIS LABORATORIES | ₹167,975.0 Cr | -1.3% | 4.5% | 16.2% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹145,804.0 Cr | -0.7% | 6.9% | 47.8% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹108,829.0 Cr | 1.3% | 5.1% | 17.5% | Stock Analytics | |
| CIPLA | ₹106,768.0 Cr | -1.9% | -0.3% | -6% | Stock Analytics | |
INNOVA CAPTAB Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| INNOVA CAPTAB | 1.5% |
-5.4% |
-7.8% |
| SENSEX | -4.1% |
-5.8% |
5.8% |
You may also like the below Video Courses